1.
Clinical and genetic aspects of neurofibromatosis 1
by Jett, Kimberly
Genetics in medicine, 2010, Vol.12 (1), p.1-11
2.
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
by Brems, Hilde, MSc
The lancet oncology, 2009, Vol.10 (5), p.508-515
3.
4.
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
by Ferner, Rosalie E
Journal of Medical Genetics, 2007, Vol.44 (2), p.81-88
5.
Neurofibromatosis type 2
by Asthagiri, Ashok R, Dr
The Lancet (British edition), 2009, Vol.373 (9679), p.1974-1986
6.
Large dilatation of wirsung duct in a patient with type-1 neurofibromatosis
by González-Abós, C
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022, Vol.22 (3), p.e10-e10
7.
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
by Hexter, Adam
Journal of Medical Genetics, 2015, Vol.52 (10), p.699-705
8.
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial
by Fisher, Michael J
Nature medicine, 2021, Vol.27 (1), p.165-173
9.
Neurofibromatosis type 1 (NF1) with an unusually severe phenotype due to digeny for NF1 and ryanodine receptor 1 associated myopathy
by Martin, Florence
European journal of pediatrics, 2014, Vol.173 (12), p.1691-1694
10.
Neurofibromatosis type 1 (NF1): diagnosis and management
by FERNER, ROSALIE
Peripheral Nerve Disorders, 2013, p.939-955
11.
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
by Mautner, V-F
Journal of medical genetics, 2010, Vol.47 (9), p.623-630
12.
Colonic Clear Cell Sarcoma Associated With Neurofibromatosis Type 2
by Sayah, Maryam
American journal of clinical pathology, 2015, Vol.144 (suppl_2), p.A409-A409
13.
Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI
by Reinert, Christian Philipp
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (3), p.776-787
14.
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
by Evans, D G R
Journal of medical genetics, 2002, Vol.39 (5), p.311-314
15.
Association of intraneural perineurioma with neurofibromatosis type 2
by Pendleton, Courtney
Acta neurochirurgica, 2020, Vol.162 (8), p.1891-1897
16.
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome
by Wang, Daphne L
Genetics in medicine, 2012, Vol.14 (12), p.977-982
17.
The association of spinal deformity with dural ectasia in neurofibromatosis type 1
by Shah, Savan
British journal of neurosurgery, 2019, Vol.33 (6), p.620-623
18.
The molecular landscape of glioma in patients with Neurofibromatosis 1
by D'Angelo, Fulvio
Nature Medicine, 2019, Vol.25 (1), p.176-187
19.
Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1)
by Eijk, Simone
Journal of autism and developmental disorders, 2018, Vol.48 (7), p.2278-2285
20.
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1
by Warbey, Victoria S
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (5), p.751-757
